BBVA Proposes €0.60 Final Dividend, €8B CoCo Authorization, and 10% Share Capital Reduction at AGM
summarizeSummary
Banco Bilbao Vizcaya Argentaria, S.A. (BBVA) has published the full agenda for its Annual General Shareholders' Meeting, detailing proposals for a €0.60 gross final dividend for 2025, authorization to issue up to €8 billion in CoCo securities, and a 10% share capital reduction.
check_boxKey Events
-
Proposed Final Dividend
Shareholders to vote on a €0.60 gross final dividend for the 2025 financial year, payable on April 10, 2026, bringing the total 2025 dividend to €5.26 billion.
-
CoCo Securities Authorization
Board seeks authorization to issue up to €8 billion in contingently convertible securities (CoCos) over five years, enhancing regulatory capital flexibility.
-
Share Capital Reduction
Proposal to reduce share capital by up to 10% through the redemption of own shares, aiming to optimize capital structure.
-
Share Buyback Program
Authorization sought for a new program to acquire up to 10% of own shares over five years, replacing a prior authorization.
auto_awesomeAnalysis
This filing provides the comprehensive details for BBVA's upcoming Annual General Shareholders' Meeting, formalizing several key capital management and financial flexibility initiatives. The proposed €0.60 gross final dividend for 2025, combined with the interim dividend, represents a substantial capital return to shareholders. The authorization to issue up to €8 billion in contingently convertible securities (CoCos) provides the bank with significant flexibility to meet future regulatory capital requirements. Additionally, the proposals for a new share buyback program and a 10% share capital reduction underscore the bank's commitment to optimizing its capital structure and enhancing shareholder value. These resolutions, if approved, will have a material impact on the bank's financial position and shareholder returns.
At the time of this filing, BBVA was trading at $22.76 on NYSE in the Finance sector, with a market capitalization of approximately $133.8B. The 52-week trading range was $11.59 to $26.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.